IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections
Lucas M. Kimmig, David Wu, Matthew Gold, Natasha N Pettit, David Pitrak, Jeffery Mueller, Aliya N. Husain, Ece A. Mutlu, View ORCID ProfileGökhan M. Mutlu
doi: https://doi.org/10.1101/2020.05.15.20103531
Lucas M. Kimmig
1Department of Medicine, University of Chicago, Chicago, Illinois
2Section of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Illinois
MDDavid Wu
1Department of Medicine, University of Chicago, Chicago, Illinois
2Section of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Illinois
MD, PhDMatthew Gold
1Department of Medicine, University of Chicago, Chicago, Illinois
MDNatasha N Pettit
1Department of Medicine, University of Chicago, Chicago, Illinois
3Section of Infectious Diseases, University of Chicago, Chicago, Illinois
PharmDDavid Pitrak
1Department of Medicine, University of Chicago, Chicago, Illinois
3Section of Infectious Diseases, University of Chicago, Chicago, Illinois
MDJeffery Mueller
4Department of Pathology, University of Chicago, Chicago, Illinois
DOAliya N. Husain
4Department of Pathology, University of Chicago, Chicago, Illinois
MDEce A. Mutlu
5Section of Gastroenterology and Hepatology, Rush University, Chicago, Illinois
MD, MS, MBAGökhan M. Mutlu
1Department of Medicine, University of Chicago, Chicago, Illinois
2Section of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Illinois
MD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted July 06, 2020.
IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections
Lucas M. Kimmig, David Wu, Matthew Gold, Natasha N Pettit, David Pitrak, Jeffery Mueller, Aliya N. Husain, Ece A. Mutlu, Gökhan M. Mutlu
medRxiv 2020.05.15.20103531; doi: https://doi.org/10.1101/2020.05.15.20103531
IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections
Lucas M. Kimmig, David Wu, Matthew Gold, Natasha N Pettit, David Pitrak, Jeffery Mueller, Aliya N. Husain, Ece A. Mutlu, Gökhan M. Mutlu
medRxiv 2020.05.15.20103531; doi: https://doi.org/10.1101/2020.05.15.20103531
Subject Area
Subject Areas
- Addiction Medicine (342)
- Allergy and Immunology (665)
- Anesthesia (180)
- Cardiovascular Medicine (2625)
- Dermatology (222)
- Emergency Medicine (397)
- Epidemiology (12176)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4064)
- Geriatric Medicine (385)
- Health Economics (676)
- Health Informatics (2625)
- Health Policy (997)
- Hematology (360)
- HIV/AIDS (845)
- Medical Education (398)
- Medical Ethics (109)
- Nephrology (430)
- Neurology (3834)
- Nursing (209)
- Nutrition (570)
- Oncology (2008)
- Ophthalmology (581)
- Orthopedics (238)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (471)
- Pediatrics (1107)
- Primary Care Research (447)
- Public and Global Health (6499)
- Radiology and Imaging (1390)
- Respiratory Medicine (869)
- Rheumatology (400)
- Sports Medicine (338)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)